Literature DB >> 27997268

Impaired ApoB-Lipoprotein and Triglyceride Metabolism in Obese Adolescents With Polycystic Ovary Syndrome.

Donna F Vine1, Ye Wang1, Mary M Jetha2, Geoff D Ball2, Spencer D Proctor1.   

Abstract

CONTEXT: Adolescents with polycystic ovary syndrome (PCOS) have atherogenic dyslipidemia and increased cardiovascular disease (CVD) risk, and this is exacerbated in obesity.
OBJECTIVE: To determine and compare fasting and nonfasting lipid and apolipoprotein (Apo)B-lipoprotein metabolism in 3 groups of adolescent girls: healthy-weight controls, obese without PCOS (obese-control), and obese with PCOS (obese-PCOS). DESIGN, SETTING, AND PARTICIPANTS: Participants aged 12 to 17 years were recruited for this cross-sectional study from a pediatric weight management clinic and the local community in Alberta, Canada. MAIN OUTCOME MEASURES: Plasma lipids and ApoB lipoproteins, including triglycerides (TGs) and ApoB100- and ApoB48-lipoproteins, were measured in the fasted and postprandial state following a high-fat meal.
RESULTS: Obese-control (n = 12) and obese-PCOS (n = 18) groups had twofold higher concentrations of fasting plasma TG and ApoB100- and ApoB48-lipoprotein remnants compared to healthy-weight controls (n = 10) (ApoB48-lipoproteins: 19.32 ± 2.10, 24.02 ± 4.28, and 8.95 ± 1.05 μg/mL, respectively; P < 0.001). The obese-PCOS group had 50% higher fasting plasma TG level compared to the obese-control group. The postprandial response was higher in both obese-controls and obese-PCOS subjects compared with healthy-weight controls in plasma TG area under the curve (AUC) (1028.0 ± 83.67, 1587.01 ± 259.6, and 615.42 ± 76.42 μg/mL⋅h, respectively; P < 0.01) and ApoB48(AUC) (191.30 ± 19.06, 238.8 ± 37.73, and 96.58 ± 9.17 μg/mL⋅h, respectively; P < 0.0001). Nonfasting plasma TG(AUC) and ApoB48(AUC) were positively correlated with free testosterone (r = 0.38; P < 0.001 and r = 0.33; P < 0.05, respectively), and these relationships were highly associated with insulin and body mass index.
CONCLUSIONS: Adolescent girls with obesity and PCOS have elevated fasting and postprandial plasma TG and ApoB-lipoprotein remnants, providing evidence of early subclinical CVD risk, and these indices are highly associated with impaired insulin metabolism and hyperandrogenemia.
Copyright © 2017 by the Endocrine Society

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27997268     DOI: 10.1210/jc.2016-2854

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  13 in total

1.  Loss of hepatic PPARα promotes inflammation and serum hyperlipidemia in diet-induced obesity.

Authors:  David E Stec; Darren M Gordon; Jennifer A Hipp; Stephen Hong; Zachary L Mitchell; Natalia R Franco; J Walker Robison; Christopher D Anderson; Donald F Stec; Terry D Hinds
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-09-04       Impact factor: 3.619

2.  Effect of metformin and flutamide on insulin, lipogenic and androgen-estrogen signaling, and cardiometabolic risk in a PCOS-prone metabolic syndrome rodent model.

Authors:  M Kupreeva; A Diane; R Lehner; R Watts; M Ghosh; S Proctor; D Vine
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-08-28       Impact factor: 4.310

3.  The Lipid Profiles in Different Characteristics of Women with PCOS and the Interaction Between Dyslipidemia and Metabolic Disorder States: A Retrospective Study in Chinese Population.

Authors:  Fei Guo; Zhentao Gong; Taniya Fernando; Lingshan Zhang; Xiaoyong Zhu; Yingli Shi
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-04       Impact factor: 6.055

4.  Effects of metformin on blood lipid profiles in nondiabetic adults: a meta-analysis of randomized controlled trials.

Authors:  Shuwei Weng; Yonghong Luo; Ziyu Zhang; Xin Su; Daoquan Peng
Journal:  Endocrine       Date:  2020-01-16       Impact factor: 3.633

5.  Postprandial Dyslipidemia, Hyperinsulinemia, and Impaired Gut Peptides/Bile Acids in Adolescents with Obesity.

Authors:  Victoria Higgins; Shervin Asgari; Jill K Hamilton; Anna Wolska; Alan T Remaley; Bolette Hartmann; Jens J Holst; Khosrow Adeli
Journal:  J Clin Endocrinol Metab       Date:  2020-04-01       Impact factor: 5.958

6.  Detecting PCOS susceptibility loci from genome-wide association studies via iterative trend correlation based feature screening.

Authors:  Xiaotian Dai; Guifang Fu; Randall Reese
Journal:  BMC Bioinformatics       Date:  2020-05-04       Impact factor: 3.169

7.  A Pilot Trial: Fish Oil and Metformin Effects on ApoB-Remnants and Triglycerides in Women With Polycystic Ovary Syndrome.

Authors:  Donna Vine; Ethan Proctor; Olivia Weaver; Mahua Ghosh; Katerina Maximova; Spencer Proctor
Journal:  J Endocr Soc       Date:  2021-06-19

8.  Comparative omics and feeding manipulations in chicken indicate a shift of the endocrine role of visceral fat towards reproduction.

Authors:  Susanne Bornelöv; Eyal Seroussi; Sara Yosefi; Sharon Benjamini; Shoval Miyara; Mark Ruzal; Manfred Grabherr; Nima Rafati; Anna-Maja Molin; Ken Pendavis; Shane C Burgess; Leif Andersson; Miriam Friedman-Einat
Journal:  BMC Genomics       Date:  2018-04-26       Impact factor: 3.969

9.  Postprandial Dyslipidemia: Pathophysiology and Cardiovascular Disease Risk Assessment.

Authors:  Victoria Higgins; Khosrow Adeli
Journal:  EJIFCC       Date:  2017-10-10

10.  Postprandial dyslipidemia in insulin resistant states in adolescent populations.

Authors:  Victoria Higgins; Khosrow Adeli
Journal:  J Biomed Res       Date:  2020-01-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.